EurekaMag
+ Translate
+ Most Popular
Advantages and disadvantages of bordeaux mixture and of lime-sulphur used on apples in the growing season
Observations on the Umaria marine bed
10 years of hearing conservation in the Royal Air Force
Chocolate crumb - dairy ingredient for milk chocolate
Effect of daily gelatin ingestion on human scalp hair
Comparison of rice bran and maize bran as feeds for growing and fattening pigs
The composition of pampas-grass (Cortaderia argentea.)
The Accraian Series:
The mechanism of the Liebermann-Burchard reaction of sterols and triterpenes and their esters
Cerebrovascular Doppler ultrasound studies (cv-Doppler)
Toria: PT-303 - first national variety
Hair growth promoting activity of tridax procumbens
Productivity of Pekin x Khaki Campbell ducks
A stable cytosolic expression of VH antibody fragment directed against PVY NIa protein in transgenic potato plant confers partial protection against the virus
Solar treatment of wheat loose smut
Swimmers itch in the Lake of Garda
Bactofugation and the Bactotherm process
The effects of prefrontal lobotomy on aggressive behavior in dogs
Visual rating scales for screening whorl-stage corn for resistance to fall armyworm
Breakdown of seamounts at the trench axis, viewed from gravity anomaly
Kooken; pennsylvania's toughest cave
Recovery of new dinosaur and other fossils from the Early Cretaceous Arundel Clay facies (Potomac Group) of central Maryland, U.S.A
Zubor horny (Bison bonasus) v prirodnych podmienkach Slovensku
The extended Widal test in the diagnosis of fevers due to Salmonella infection
Hair of the american mastodon indicates an adaptation to a semi aquatic habitat

The primary and secondary cellular immune responses to whole cell Bordetella pertussis vaccine and its components


The primary and secondary cellular immune responses to whole cell Bordetella pertussis vaccine and its components



Clinical and Experimental Immunology 68(2): 275-281



ISSN/ISBN: 0009-9104

PMID: 3498569

The cellular immune responses of Balb/c mice and Wistar rats immunized in hind footpads with intact killed Bordetella pertussis were found to differ from those of similar animals immunized with other bacteria including Bordetella bronchiseptica, Salmonella typhimurium and Escherichia coli. All the bacteria stimulated increases in cell number, proliferation and interleukin 2 (IL-2) production in popliteal lymph nodes which peaked 3-5 days after injection and decreased to resting levels by day 7. However, B. pertussis also caused a second peak in all three parameters at 11 days after immunization. This peak was not seen following injection with any of the other bacteria. Bordetella pertussis also caused systemic effects, increased cellular proliferation in bone marrow and thymus, with similar biphasic kinetics. It possesses a potent toxin, distinguishing it from the closely related B. bronchiseptica. The use of purified materials confirmed that the presence of this pertussis toxin (PT) was responsible for the later peak in stimulation, whereas lipopolysaccharide (LPS) in combination with PT and also the filamentous haemagglutinin (FHA) could mimic the early peak of stimulation. Primary immunization with B. pertussis was also shown to generate lymph node cells which responded in vitro to secondary challenge with B. pertussis cells, FHA or PT. Both proliferation and IL-2 production were enhanced, except with FHA which only increased IL-2 production. Lymph node cells from mice immunized with E. coli showed no such responses.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 006740700

Download citation: RISBibTeXText

Related references

Serum IgG, IgA, and IgM responses to pertussis toxin, filamentous hemagglutinin, and agglutinogens 2 and 3 after infection with Bordetella pertussis and immunization with whole-cell pertussis vaccine. Journal of Infectious Diseases 160(5): 838-845, 1989

Immune responses to the Bordetella pertussis antigens pertactin and pertussis toxin expressed in Salmonella typhi vaccine strains. Abstracts of the General Meeting of the American Society for Microbiology 98: 251, 1998

Immunoblot analysis of humoral immune responses following infection with Bordetella pertussis or immunization with diphtheria-tetanus-pertussis vaccine. Journal of Clinical Microbiology 26(7): 1373-1377, 1988

Cell-mediated immunity and antibody responses to Bordetella pertussis antigens in children with a history of pertussis infection and in recipients of an acellular pertussis vaccine. Journal of Infectious Diseases 181(6): 1989-1995, 2000

Protection and humoral immune responses against Bordetella pertussis infection in mice immunized with acellular or cellular pertussis immunogens. Vaccine 19(9-10): 1118-1128, 2000

Protection and humoral immune responses against Bordetella pertussis infection in mice immunized with acellular or cellular pertussis immunogens. Vaccine 19(9-10): 1118-1128, 8 December, 2000

Cell-Mediated and Humoral Immune Responses to Bordetella pertussis Inactivated Whole-Cells Encapsulated Alginate Microspheres as a New Vaccine Candidate. Current Pharmaceutical Biotechnology 18(7): 585-593, 2017

Influence of Bordetella pertussis on the lymphatic tissue of mice. X. Further studies on the participation of lymph nodes in the primary and secondary immune response of mice to sheep erythrocytes under the influence of Bordetella pertussis. Zeitschrift für Immunitatsforschung Experimentelle und Klinische Immunologie 147(1): 27-43, 1974

Influence of bordetella pertussis on the lymphatic tissue of mice part 10 further studies on the participation of lymph nodes in the primary and secondary immune response of mice to sheep erythrocytes under the influence of bordetella pertussis. Zeitschrift fuer Immunitaetsforschung Experimentelle und Klinische Immunologie 147(1): 27-43, 1974

Sequence variation in pertussis S1 subunit toxin and pertussis genes in Bordetella pertussis strains used for the whole-cell pertussis vaccine produced in Poland since 1960Efficiency of the DtwP vaccine-induced immunity against currently circulating B. pertussis isolates. Vaccine 22(17-18): 2122-2128, 2004

Sequence variation in pertussis S1 subunit toxin and pertussis genes in Bordetella pertussis strains used for the whole-cell pertussis vaccine produced in Poland since 1960: efficiency of the DTwP vaccine-induced immunity against currently circulating B. pertussis isolates. Vaccine 22(17-18): 2122-2128, 2004

Influence of Bordetella pertussis on the lymphatic tissue of mice. 8. The influence of Bordetella pertussis on the primary and secondary immune potential of thymusless ("nude") mice. Medical Microbiology and Immunology 159(1): 13-38, 1973

Chemical Studies on Cellular Components of Bordetella Pertussis. Iii. Isolation of Highly Potent Toxin from Bordetella Pertussis. Journal of Bacteriology 86: 648-655, 1963

Hepatitis B component does not interfere with the immune response to diphtheria, tetanus and whole-cell Bordetella pertussis components of a quadrivalent (DTPw-HB) vaccine: A controlled trial in healthy infants. Vaccine 15(12-13): 1418-1422, 1997

Two primary doses of diphtheria-tetanus-acellular pertussis vaccine induce immunological responses to Bordetella pertussis as strong as those induced by three primary doses. Vaccine 15(17-18): 1955-1958, 1997